Terms: = Leukemia AND FANCG, ENSG00000221829, 2189, O15287, XRCC9, FAG
42 results:
1. [Treatment responses, outcomes, and prognostic factors associated with them in patients with secondary acute myeloid leukemia].
Ma L; Zhao T; Chen YY; Jiang H; Xu LP; Zhang XH; Wang Y; Sun YQ; Mo XD; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):124-131. PubMed ID: 36948866
[No Abstract] [Full Text] [Related]
2. Mesenchymal stem/stromal cells from a transplanted, asymptomatic patient with Fanconi anemia exhibit an aging-like phenotype and dysregulated expression of genes implicated in hematopoiesis and myelodysplasia.
Haga CL; Boregowda SV; Booker CN; Krishnappa V; Strivelli J; Cappelli E; Phinney DG
Cytotherapy; 2023 Apr; 25(4):362-368. PubMed ID: 36481320
[TBL] [Abstract] [Full Text] [Related]
3. Genetic analysis of a Fanconi anemia case revealed the presence of FANCF mutation (exon 1;469>C-T) with implications to develop acute myeloid leukemia.
Behera CK; Gyandeep G; Mishra R; Mohanty RP; Pal A; Behera J; Samal S; Das B
Mol Biol Rep; 2023 Jan; 50(1):931-936. PubMed ID: 36369330
[TBL] [Abstract] [Full Text] [Related]
4. Fanconi anemia gene-associated germline predisposition in aplastic anemia and hematologic malignancies.
Nie D; Zhang J; Wang F; Li X; Liu L; Zhang W; Cao P; Chen X; Zhang Y; Chen J; Ma X; Zhou X; Wu Q; Liu M; Liu M; Tian W; Liu H
Front Med; 2022 Jun; 16(3):459-466. PubMed ID: 34741701
[TBL] [Abstract] [Full Text] [Related]
5. Promyelocytic leukemia Proteins Regulate Fanconi Anemia Gene Expression.
Munkhjargal A; Kim MJ; Kim DY; Jeon YJ; Kee YH; Kim LK; Kim YH
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360546
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission.
Machova Polakova K; Zizkova H; Zuna J; Motlova E; Hovorkova L; Gottschalk A; Glauche I; Koblihova J; Pecherkova P; Klamova H; Stastna Markova M; Srbova D; Benesova A; Polivkova V; Jurcek T; Zackova D; Mayer J; Ernst T; Mahon FX; Saussele S; Roeder I; Cross NCP; Hochhaus A
Leukemia; 2020 Aug; 34(8):2113-2124. PubMed ID: 32472084
[TBL] [Abstract] [Full Text] [Related]
7. Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia.
Yabe M; Koike T; Ohtsubo K; Imai E; Morimoto T; Takakura H; Koh K; Yoshida K; Ogawa S; Ito E; Okuno Y; Muramatsu H; Kojima S; Matsuo K; Mori M; Hira A; Takata M; Yabe H
Ann Hematol; 2019 Feb; 98(2):271-280. PubMed ID: 30368588
[TBL] [Abstract] [Full Text] [Related]
8. The utility of routine pre-chemotherapy screening with cardiac gated blood pool scan for patients at low risk of anthracycline toxicity.
Chia PL; Chiang K; Snyder R; Dowling A
J Oncol Pharm Pract; 2018 Jun; 24(4):264-271. PubMed ID: 29284360
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of aprepitant for acute chemotherapy-induced nausea and vomiting in children and adolescents with acute lymphoblastic leukemia receiving high-dose methotrexate.
Felix-Ukwu F; Reichert K; Bernhardt MB; Schafer ES; Berger A
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29031010
[TBL] [Abstract] [Full Text] [Related]
10. Serious fungal infections in Chile.
Alvarez Duarte E; Denning DW
Eur J Clin Microbiol Infect Dis; 2017 Jun; 36(6):983-986. PubMed ID: 28188493
[TBL] [Abstract] [Full Text] [Related]
11. Time-Dependent Risk of Cancer After a Diabetes Diagnosis in a Cohort of 2.3 Million Adults.
Dankner R; Boffetta P; Balicer RD; Boker LK; Sadeh M; Berlin A; Olmer L; Goldfracht M; Freedman LS
Am J Epidemiol; 2016 Jun; 183(12):1098-106. PubMed ID: 27257115
[TBL] [Abstract] [Full Text] [Related]
12. Clinical characteristics and genetic subtypes of Fanconi anemia in Saudi patients.
Ghazwani Y; AlBalwi M; Al-Abdulkareem I; Al-Dress M; Alharbi T; Alsudairy R; Alomari A; Aljamaan K; Essa M; Al-Zahrani M; Alsultan A
Cancer Genet; 2016 Apr; 209(4):171-6. PubMed ID: 26968956
[TBL] [Abstract] [Full Text] [Related]
13. Feasibility and efficacy of outpatient therapy with intermediate dose cytarabine, fludarabine and idarubicin for patients with acute myeloid leukaemia aged 70 or older.
Vives S; Oriol A; Piernas S; Brunet S; Clapés V; Guardia R; Subirà M; Sierra J; Ribera JM;
Eur J Haematol; 2015 Dec; 95(6):576-82. PubMed ID: 25692738
[TBL] [Abstract] [Full Text] [Related]
14. [Expression of fancg gene in acute myeloid leukemia].
Duan XL; Wang QL; Wang JG; Wang CY; Fan H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):7-11. PubMed ID: 23484681
[TBL] [Abstract] [Full Text] [Related]
15. Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AML.
Christopoulos P; Schmoor C; Waterhouse M; Marks R; Wäsch R; Bertz H; Finke J
Bone Marrow Transplant; 2013 Jul; 48(7):901-7. PubMed ID: 23376820
[TBL] [Abstract] [Full Text] [Related]
16. Fanconi anemia.
Soulier J
Hematology Am Soc Hematol Educ Program; 2011; 2011():492-7. PubMed ID: 22160080
[TBL] [Abstract] [Full Text] [Related]
17. Impaired functionality and homing of fancg-deficient hematopoietic stem cells.
Barroca V; Mouthon MA; Lewandowski D; Brunet de la Grange P; Gauthier LR; Pflumio F; Boussin FD; Arwert F; Riou L; Allemand I; Romeo PH; Fouchet P
Hum Mol Genet; 2012 Jan; 21(1):121-35. PubMed ID: 21968513
[TBL] [Abstract] [Full Text] [Related]
18. GS-nitroxide (JP4-039)-mediated radioprotection of human Fanconi anemia cell lines.
Bernard ME; Kim H; Berhane H; Epperly MW; Franicola D; Zhang X; Houghton F; Shields D; Wang H; Bakkenist CJ; Frantz MC; Forbeck EM; Goff JP; Wipf P; Greenberger JS
Radiat Res; 2011 Nov; 176(5):603-12. PubMed ID: 21939290
[TBL] [Abstract] [Full Text] [Related]
19. Identification and characterization of mutations in FANCL gene: a second case of Fanconi anemia belonging to FA-L complementation group.
Ali AM; Kirby M; Jansen M; Lach FP; Schulte J; Singh TR; Batish SD; Auerbach AD; Williams DA; Meetei AR
Hum Mutat; 2009 Jul; 30(7):E761-70. PubMed ID: 19405097
[TBL] [Abstract] [Full Text] [Related]
20. The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells.
Scuto A; Kirschbaum M; Kowolik C; Kretzner L; Juhasz A; Atadja P; Pullarkat V; Bhatia R; Forman S; Yen Y; Jove R
Blood; 2008 May; 111(10):5093-100. PubMed ID: 18349321
[TBL] [Abstract] [Full Text] [Related]
[Next]
